About me
1997 Research Assistant: Department of Medical Biochemistry, Flinders University
1998-1999 Research Assistant at the Department of Cytogenetics, Women’s and Children’s Hospital. South Australia
2004-2011 Postdoctoral Researcher: Cell Growth and Differentiation Laboratory, Department of Human Immunology, Centre for Cancer Biology, Adelaide.
2012- Head, Cancer Cell Signalling Unit, Molecular Signalling Laboratory, Department of Human Immunology, Centre for Cancer Biology, Adelaide. Laboratory Head: Professor Stuart Pitson
2017- Associate faculty member of the Center of Cancer Biology
2011-2021 Affiliate Senior Lecturer, Discipline of Medicine, Faculty of Health Sciences, University of Adelaide
2016-2019 Adjunct Senior research fellow, School of Pharmacy and Medical Sciences, University of South Australia
2018- Member of the executive committee, South Australian Cancer Biobank (SACRB) 2019- Member of the Australian patient derived xenograph consortium
Research
Excludes commercial-in-confidence projects.
Bioengineering a Superior Humanized Haematopoietic Niche Derived from Mesenchymal Stem Cells for Pre-Clinical Avatar Cancer Trials, MRFF-Stem Cell Therapies Mission, 01/08/2023 - 31/07/2025
Examining the pathogenic bone marrow microenvironment, HSC stress, and targeting clonal evolution to prevent development of leukaemia in predisposed individuals, Leukaemia Foundation - Grant in Aid (National Research Program), 10/07/2023 - 09/05/2025
Stereotactic alignment and injection system for the generation of xenografts of human brain tumours into the brains of mice for pre-clinical testing of new and existing therapeutics, Neurosurgical Research Foundation, 01/01/2018 - 31/12/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID
Open access indicates that an output is open access.
Year | Output |
---|---|
2024 |
Open access
1
|
2024 |
Open access
1
|
2024 |
Open access
1
1
|
2023 |
27
268
|
2023 |
Open access
9
12
|
2022 |
Open access
10
11
9
|
2022 |
Open access
14
13
3
|
2022 |
Open access
24
21
71
|
2022 |
Open access
7
6
1
|
2022 |
Open access
9
9
90
|
2019 |
Open access
19
18
5
|
2019 |
Open access
11
11
|
2019 |
Open access
11
11
1
|
2018 |
Open access
55
58
1
|
2017 |
Open access
62
63
56
|
2017 |
Open access
29
27
|
2016 |
Open access
50
47
|
2015 |
Open access
62
58
|
2014 |
Open access
65
61
|
2013 |
Open access
14
13
|
External engagement & recognition
Organisation | Country |
---|---|
Australian National University | AUSTRALIA |
Flinders University | AUSTRALIA |
Harvard University | UNITED STATES |
Monash University | AUSTRALIA |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
SA Pathology | AUSTRALIA |
St. Vincent's Institute of Medical Research | AUSTRALIA |
Stanford University | UNITED STATES |
University of Adelaide | AUSTRALIA |
University of New South Wales | AUSTRALIA |
University of North Carolina at Chapel Hill | UNITED STATES |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
University of Texas | UNITED STATES |
Victor Chang Cardiac Research Institute | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Westmead Hospital | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110188-Enhancing therapy of acute myeloid leukaemia by predicting drivers of relapse | Current |
Targeting sphingosine kinase 1 to overcome venetoclax resistance in acute myeloid leukemia | Current |
Targeting sphingosine kinase 1 in acute myeloid leukaemia | Completed |